Yong-Chun Song
Papers
2
Total Citations
16
H-Index
2
About
Dr. Yong-Chun Song is a leading clinical researcher in radiation oncology, with a focused expertise in robotic stereotactic body radiation therapy (SBRT) for complex oncologic cases. His work has significantly advanced the safety and precision of treating both primary liver cancers and metastatic spinal disease. In his landmark 2017 study on hepatocellular carcinoma (HCC), Dr. Song analyzed a multi-institutional cohort of 74 patients, identifying critical factors that influence the safety of robotic SBRT in this challenging population. This work has been cited 9 times and serves as a foundational reference for clinicians seeking to minimize toxicity while maximizing tumor control. Earlier, in 2014, Dr. Song addressed the formidable challenge of spinal metastases, demonstrating that robotic SBRT offers a safe and effective option—even for reirradiation—by precisely limiting dose to the spinal cord. Garnering 7 citations, this study provided crucial evidence that high-dose radiation can be delivered to the spine without prohibitive risk. Through these contributions, Dr. Song has helped establish robotic SBRT as a viable, targeted alternative to conventional radiotherapy, improving outcomes for patients with some of the most difficult-to-treat cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2